BCYC earnings date and last-quarter result: next report 2026-08-14, last quarter miss, P/E -1.34. Updated 2026-07-23.
Bicycle Therapeutics (BCYC) Research Hub
Bicycle Therapeutics (BCYC) trades on NASDAQ, GB in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 3.65 USD (+2.82%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -1.34, market cap 0.29B. This hub links to the full technical, earnings and options research available for BCYC.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, GB |
| Last close | 3.65 USD (+2.82%) |
| 52-week range | 3.33 USD – 4.51 USD |
| Trend regime | Range |
| 14-day RSI | 44.4 (Bearish) |
| Trailing P/E | -1.34 |
| Market cap | 0.29B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-14 |
Available research for BCYC
Covered Call on BCYC: how it works, illustrative setup around the real 3.65 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on BCYC: how it works, illustrative setup around the real 3.65 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on BCYC: how it works, illustrative setup around the real 3.65 USD price, max profit/loss, breakeven and when to use it. Educational.
BCYC technical analysis: range, last 3.65 USD, RSI 44.4, 52w range 3.33 USD–4.51 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is BCYC in?
Bicycle Therapeutics (BCYC) is classified under Healthcare (Biotechnology), listed on NASDAQ, GB.
Is BCYC in an uptrend or downtrend?
As of 2026-10-26, BCYC is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is BCYC's trailing P/E ratio?
BCYC's trailing P/E is -1.34, with a market cap of 0.29B. See the earnings research page for full valuation detail.
When does BCYC next report earnings?
BCYC is next scheduled to report earnings on 2026-08-14.